Events and Presentations


There are currently no events to display.


Date Event Details Remind Me
Summary Toggle 08/5/09
4:00 PM EDT
Summary Toggle 08/17/11
9:10 AM EDT
Summary Toggle 11/27/12
9:30 AM EST
Summary Toggle 05/7/14
8:40 AM EDT
Summary Toggle 11/7/16
5:30 PM EST
Summary Toggle 05/5/11
5:00 PM EDT
Summary Toggle 10/13/12
4:00 AM EDT
Principal investigator, Jerry R. Mendell, M.D. of Nationwide Children's Hospital, will present the data via an oral presentation of the abstract titled, "Results at 48 Weeks of a Phase IIb Extension Study of the Exon-Skipping Drug Eteplirsen in Patients with Duchenne muscular dystrophy (DMD)." Dr. Mendell will present on October 13 at 4:00 p.m. WST UTC +8 hours/4:00 a.m. EDT.
Summary Toggle 04/21/14
8:00 AM EDT
Summary Toggle 10/1/15
7:00 AM EDT
Summary Toggle 03/10/11
5:00 PM EST

This section of our website may contain dated or archived information which should not be considered current and may no longer be accurate. For current information, you are encouraged to review our most recent official corporate documents on file with the U.S. Securities and Exchange Commission.
Sarepta's recorded events and presentations contain forward-looking statements that involve risks and uncertainties, including, but not limited to, the results of research and development efforts, the results of preclinical and clinical testing, the effect of regulation by the FDA and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the company's Securities and Exchange Commission filings. Sarepta undertakes no obligation to revise or update the progress of these milestones except to the extent required under applicable federal and state securities laws.